| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase Mutations
|
Salhotra, Amandeep
|
|
2019
|
19 |
7 |
p. e400-e405
|
artikel
|
| 2 |
Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML: Transplantation in CR1 Is the Decisive Factor for Good Outcome
|
Jindra, Pavel
|
|
2019
|
19 |
7 |
p. 462-469
|
artikel
|
| 3 |
Anthracycline-Induced Cardiotoxicity in Acute Myeloid Leukemia Patients Who Undergo Allogeneic Hematopoietic Stem Cell Transplantation
|
Pasvolsky, Oren
|
|
2019
|
19 |
7 |
p. e343-e348
|
artikel
|
| 4 |
Autologous Hematopoietic Cell Transplantation Versus Chemotherapy Alone for Immunoglobulin Light Chain Amyloidosis: A Retrospective Study
|
Miyazaki, Kanji
|
|
2019
|
19 |
7 |
p. 413-422.e5
|
artikel
|
| 5 |
Correlation of MicroRNA 17-92 Cluster Host Gene (MIR17HG) Polymorphisms With Susceptibility and Prognosis for Multiple Myeloma
|
Wu, Hongbo
|
|
2019
|
19 |
7 |
p. e359-e366
|
artikel
|
| 6 |
Editorial Board
|
|
|
2019
|
19 |
7 |
p. A5-A6
|
artikel
|
| 7 |
Favorable Outcomes With Tumor Burden Reduction Following Administration of Hypomethylating Agents Before Allogeneic Hematopoietic Cell Transplantation in Patients With Higher Risk Myelodysplastic Syndrome
|
Park, Sungwoo
|
|
2019
|
19 |
7 |
p. e367-e373
|
artikel
|
| 8 |
Future of Personalized Therapy Targeting Aberrant Signaling Pathways in Multiple Myeloma
|
Anwer, Faiz
|
|
2019
|
19 |
7 |
p. 397-405
|
artikel
|
| 9 |
High Level of Serum Soluble Interleukin-2 Receptor Is Associated With Poor Survival in Patients With First Relapsed or Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified: A Retrospective Study
|
Morita-Fujita, Mari
|
|
2019
|
19 |
7 |
p. e337-e342
|
artikel
|
| 10 |
Incidence, Clinical Features, and Outcomes of Langerhans Cell Sarcoma in the United States
|
Tella, Sri Harsha
|
|
2019
|
19 |
7 |
p. 441-446
|
artikel
|
| 11 |
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life Experience
|
Marangon, Miriam
|
|
2019
|
19 |
7 |
p. e321-e323
|
artikel
|
| 12 |
Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma
|
Khouri, Jack
|
|
2019
|
19 |
7 |
p. e374-e376
|
artikel
|
| 13 |
Minimal Residual Disease and Survival Outcomes in Patients With Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis
|
Molica, Stefano
|
|
2019
|
19 |
7 |
p. 423-430
|
artikel
|
| 14 |
Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual MeetingĀ 2018
|
Terpos, Evangelos
|
|
2019
|
19 |
7 |
p. e324-e336
|
artikel
|
| 15 |
Nutrition-Related Outcomes for Autologous Stem Cell Transplantation Patients
|
Lazarow, Heather
|
|
2019
|
19 |
7 |
p. e393-e398
|
artikel
|
| 16 |
Optimal Time Points for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis on the Basis of European LeukemiaNet Recommendations in Chronic Myeloid Leukemia
|
Yoo, Hea-Lyun
|
|
2019
|
19 |
7 |
p. 406-412.e1
|
artikel
|
| 17 |
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study
|
Ragon, Brittany Knick
|
|
2019
|
19 |
7 |
p. 431-440.e13
|
artikel
|
| 18 |
p53 and Ī²-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma
|
Richardson, Aida Ibricevic
|
|
2019
|
19 |
7 |
p. e385-e392
|
artikel
|
| 19 |
Platelet Counts and Risk of Major Bleeding With Ibrutinib
|
Lucijanic, Marko
|
|
2019
|
19 |
7 |
p. e399
|
artikel
|
| 20 |
Pomalidomide-Based Regimens for Treatment of Relapsed and Relapsed/Refractory Multiple Myeloma: Systematic Review and Meta-analysis of Phase 2 and 3 Clinical Trials
|
Mushtaq, Adeela
|
|
2019
|
19 |
7 |
p. 447-461
|
artikel
|
| 21 |
Prognostic and Therapeutic Value of Day 14 Bone Marrow Aspiration in Adult Acute Myeloid Leukemia Patients
|
El Gammal, Mosaad M.
|
|
2019
|
19 |
7 |
p. e406-e413
|
artikel
|
| 22 |
Study on the Prognostic Value of Aberrant Antigen in Patients With Acute B Lymphocytic Leukemia
|
Liu, Jun
|
|
2019
|
19 |
7 |
p. e349-e358
|
artikel
|
| 23 |
Table of Contents
|
|
|
2019
|
19 |
7 |
p. A7, A15-A16, A22-A23
|
artikel
|
| 24 |
The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations
|
Soysal, Teoman
|
|
2019
|
19 |
7 |
p. e377-e384
|
artikel
|
Tijdschrift beschrijving